Why Is Contineum Therapeutics Stock Falling Monday?

Contineum Therapeutics Inc. (NASDAQ:CTNM) stock plunged Monday following mixed Phase 3 trial results for Bristol Myers Squibb & Co.’s (NYSE:BMY) competing lung disease drug, admilparant.Bristol Myers Squibb reported topline efficacy and safety results from its...